Medtronic Minimed
Medtronic MiniMed is a world leader in insulin pump therapy and continuous glucose monitoring for the treatment of diabetes. The company is committed to improving the lives of people living with diabetes and other medical conditions by providing integrated therapy solutions, including superior drug delivery and glucose monitoring devices, data management tools, pharmaceuticals and responsive customer service.MiniMed was founded in the early 1980s, the company's core business is insulin pump therapy for the treatment of Type 1 diabetes. In July 2002, MiniMed integrated with Medtronic Limited and became known worldwide as Medtronic MiniMed. More than 150,000 Medtronic MiniMed pump wearers worldwide, including customers who purchased the company's first insulin pump in 1983, are supported by a clinical services team 24 hours a day, 365 days a year. The company also assists customers training for pump initiation, and provides ongoing educational support for physicians and diabetes patients. Educational programs are directed to the healthcare community through continuing educational programs, nationwide symposia and a pump trainer program.
Medtronic MiniMed employs more than 2,000 people worldwide. Customer support (sales processing, insurance verification, clinical services, billing and collections), marketing, research and development, and the manufacturing of insulin pumps and continuous glucose monitoring systems are located at its corporate headquarters in California, USA. The international headquarters are located in Tolochenaz, Switzerland.
